Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Barakat

Showing results (271-280 of 402) with videos related to

Pageof 41
Sort By:
Gynecologic Oncology|December 4, 2013
Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancerSamith Sandadi, Kara Long, Vaagn Andikyan, et al.
American Journal of Ophthalmology|November 6, 2021
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular EdemaThomas A Ciulla, Barry Kapik, Mark R Barakat, et al.
Gynecologic Oncology|March 1, 2011
A microRNA survival signature (MiSS) for advanced ovarian cancerKarin K Shih, Li-Xuan Qin, Edward J Tanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinomaDestin Black, Robert A Soslow, Douglas A Levine, et al.
Gynecologic Oncology|August 30, 2008
Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinomaMario M Leitao, Siobhan Kehoe, Richard R Barakat, et al.
Gynecologic Oncology|November 24, 2012
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancerKarin K Shih, Sarah A Milgrom, Nadeem R Abu-Rustum, et al.
Cancer|February 24, 2005
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinomaRam Eitan, Douglas A Levine, Nadeem Abu-Rustum, et al.
Gynecologic Oncology|May 19, 2007
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapyEric L Eisenhauer, William P Tew, Douglas A Levine, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
Gynecologic Oncology|September 29, 2012
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancerEdward J Tanner, Kara C Long, Jill B Feffer, et al.
Pageof 41

Showing results (271-280 of 402) with videos related to

Sort By:
Pageof 41
Gynecologic Oncology|December 4, 2013
Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancerSamith Sandadi, Kara Long, Vaagn Andikyan, et al.
American Journal of Ophthalmology|November 6, 2021
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular EdemaThomas A Ciulla, Barry Kapik, Mark R Barakat, et al.
Gynecologic Oncology|March 1, 2011
A microRNA survival signature (MiSS) for advanced ovarian cancerKarin K Shih, Li-Xuan Qin, Edward J Tanner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 22, 2006
Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinomaDestin Black, Robert A Soslow, Douglas A Levine, et al.
Gynecologic Oncology|August 30, 2008
Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinomaMario M Leitao, Siobhan Kehoe, Richard R Barakat, et al.
Gynecologic Oncology|November 24, 2012
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancerKarin K Shih, Sarah A Milgrom, Nadeem R Abu-Rustum, et al.
Cancer|February 24, 2005
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinomaRam Eitan, Douglas A Levine, Nadeem Abu-Rustum, et al.
Gynecologic Oncology|May 19, 2007
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapyEric L Eisenhauer, William P Tew, Douglas A Levine, et al.
Gynecologic Oncology|October 11, 2011
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancerEdward J Tanner, Destin R Black, Oliver Zivanovic, et al.
Gynecologic Oncology|September 29, 2012
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancerEdward J Tanner, Kara C Long, Jill B Feffer, et al.
Pageof 41